Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

MMWR: Ten Great Public Health Achievements — Worldwide, 2001–2010

June 24, 2011


Learn more about the CDC science and programmatic work that went into the “Ten Great Public Health Achievements — Worldwide, 2001–2010” at these links:


Exit Notification

    This graphic notice (External link icon) means that you are leaving an HHS Web site.
  • This external link provides additional information that is consistent with the intended purpose of the federal site.
  • The Department of Health and Human Services (HHS) cannot attest to the accuracy of a non-federal site.
  • Linking to a non-federal site does not constitute an endorsement by HHS or any of its employees of the sponsors or the information and products presented on the site.



MMWR: Ten Great Public Health Achievements — United States, 2001–2010

May 20, 2011


Learn more about the CDC science and programmatic work that went into the “Ten Great Public Health Achievements — United States, 2001–2010” at these links:


TABLE. Healthy People 2010 improvements related to public health achievements --- United States*

Area of public health achievement

Healthy People 2010 objective measure†

Improvement

Vaccine-preventable diseases

Vaccination of each U.S. birth cohort with current childhood immunization schedule

14-24a. Proportion of children aged 19--35 months receiving the recommended vaccines

From 73% (1998) to 78% (2008)

Pneumococcal disease

14-22g. Children aged 19--35 months receiving ≥4 doses of the pneumococcal conjugate vaccine

From 20% (2002) to 80% (2008)

Varicella

14-22f. Children aged 19--35 months receiving ≥1 dose of the varicella vaccine
14-27d. Adolescents aged 13--15 years receiving ≥1 dose of the varicella vaccine (excluding those who have reported having varicella)

From 43% (1998) to 91% (2008) (14-22f) and from 45% (1997) to 86% (2008) (14-27d)

Hepatitis A

14-6. New cases of hepatitis A (per 100,000 population)

From 11.2 (1997) to 0.9 (2008)

Prevention and control of infectious diseases

Tuberculosis cases

14-11. New cases of tuberculosis (per 100,000 population)

From 6.6 (1998) to 4.2 (2008)

Central line--associated blood stream infections

14-20b. Hospital-acquired central line--associated bloodstream infections among intensive-care unit patients (per 1,000 days use)

From 5.5 (1995-98) to 1.6 (2009)

Tobacco

Adult tobacco use

27-1a. Cigarette smoking among adults aged ≥18 years (age-adjusted)

From 24% (1998) to 21% (2008)

Youth tobacco use

27-2b. Cigarette smoking among students (grades 9--12)

From 35% (1999) to 19% (2009)

States with comprehensive smoke-free laws

27-13a, b, c, i. Smoke-free indoor air laws (specific to private workplaces, public workplaces, restaurants, and bars).

From zero (1998) to 30 (2009) states (27-13a), 10 (1998) to 34 (2009) states (27-13b), one (1998) to 28 (2009) states (27-13c), and zero (1998) to 22 states (2009) (27-13i)

Combined average federal and average state excise tax

27-21a. Combined average federal and state tax on cigarettes (dollars per standard U.S. package of cigarettes)

From $0.63 (1998) to $2.35 (2009)

Maternal and infant health

Pregnancies affected by neural tube defects

16-15. Live births and fetal deaths at ≥20 weeks gestation with diagnoses of spina bifida and other neural tube defects (new cases per 10,000 live births)

From six (1996) to five (2007)

Newborn hearing screening

28-11a. Newborns receiving an objective
physiologic hearing screening procedure before age 1 month

From 66% (2001) to 82% (2007)

Motor vehicle safety

Deaths per 100,000 persons per vehicle mile traveled

15-15a. Motor vehicle deaths (age-adjusted per 100,000 standard population)
15-15b. Motor vehicle deaths (per 100 million vehicle miles traveled)

From 14.7 (1999) to 13.8 (2007) (15-15a) and from 1.6 (1998) to 1.3 (2008) (15-15b)

Injuries per 100,000 persons per vehicle mile traveled

15-17. Nonfatal motor vehicle injuries (per 100,000 population)

From 1,181 (1998) to 771 (2008)

Pedestrian deaths

15-16. Pedestrian deaths on public roads (per 100,000 population)

From 1.9 (1998) to 1.5 (2008)

Cardiovascular disease prevention

Age-adjusted coronary heart disease deaths

12-1. Coronary heart disease deaths (age-adjusted per 100,000 population)

From 195 (1999) to 126 (2007)

Age-adjusted stroke deaths

12-7. Stroke deaths (age-adjusted per 100,000 population)

From 62 (1999) to 42 (2007)

Occupational safety

Work-related injury deaths

20-1a. Work-related injury deaths -- all industries (per 100,000 workers aged ≥16 years)

From 4.5 (1998) to 3.3 (2009)

Work-related injuries

20-2a. Work-related injuries -- all industries (per 100 full-time workers)

From 6.2 (1998) to 3.4 (2009)

Cancer prevention

Colorectal cancer death rate per year

3-5. Colorectal cancer deaths (age-adjusted per 100,000 standard population)

From 20.9 (1999) to 16.9 (2007)

Breast cancer death rate per year

3-3. Female breast cancer deaths (age-adjusted per 100,000 standard population)

From 26.6 (1999) to 22.9 (2007)

Cervical cancer death rate per year

3-4. Cervical cancer deaths (age-adjusted per 100,000 standard population)

From 2.8 (1999) to 2.4 (2007)

Childhood lead poisoning prevention

% of children with blood lead levels ≥10 μg/dL

8-11. Children aged 1--5 years with blood lead levels ≥10 μg/dL

From 4.4% (1991--1994) to level too small for reliable measurement (2005--2008)

Public health preparedness and response

No related Healthy People 2010 objectives

Source: DATA2010 (Healthy People 2010 database). Available at http://wonder.cdc.gov/data2010.

* Most recent data available. The Healthy People 2010 Final Review will be published in fall 2011; data presented in this table might not be final.

† Additional information available at http://wonder.cdc.gov/data2010.


Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #